Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a diet and coaching program reverse type 2 diabetes in memphis?

NCT ID NCT07316569

Disease control Sponsor: University of Tennessee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a 6-month program combining group classes, personal coaching, and a low-carb diet to help people with early type 2 diabetes lose weight and possibly reverse their condition. It involved 35 overweight adults in low-income Memphis neighborhoods. The goal was to see if this approach could lead to diabetes remission, defined as normal blood sugar without medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intensive multicomponent healthy eating and weight loss intervention (behavioral)
What this could lead to
If successful, this program could offer a practical, low-cost way to help people with early type 2 diabetes achieve remission without medication.
What could go wrong
This is a small pilot study with only 35 participants, so results may not apply to everyone. The program requires significant lifestyle changes, and long-term success is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Oct 2023

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients must meet the following criteria to be eligible: * adults 18 years or older * a type 2 diabetes (T2D) duration of 0-6 years (diagnosis based on one recorded HbA1c test) * HbA1c value ≥ 6.5 percent at the screening visit * BMI ≥ 25 kg/m2 * access to a cell phone or smartphone with texting and voicemail capabilities Exclusion Criteria: * current use of insulin or more than two hypoglycemic medications (either oral or injectable) * a recent routine HbA1c greater than or equal to 12% * weight loss of \>5 kg within the last six months * inability to understand consent procedures, understand and speak English * pregnancy or considering pregnancy * diagnosis or exhibited unstable psychiatric condition, dementia, neurological disorder, or history of severe head trauma or brain tumor, and cognitive impairment * perceived unwillingness or inability to participate * planned move from the region during the study * participation in another clinical research trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus Obesity obesity disorder Overweight type 2 diabetes mellitus Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete type 2 Diabetes Overweight/obesity

Contacts and locations

Locations

  • UTHSC Health Hub-ShelbyCares

    Memphis, Tennessee, 38109, United States

  • UTHSC Health Hub-Uptown

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.